Eosinophils: Ancient Cells with New Roles in Chronic Lung Inflammation.
K. Asosingh,M. Aronica
DOI: https://doi.org/10.1164/rccm.201612-2435ED
IF: 24.7
2017-05-15
American Journal of Respiratory and Critical Care Medicine
Abstract:Eosinophils, first described by Paul Ehrlich in 1879 (1), are an important type of granulocyte among innate immune cells important in a broad spectrum of allergic diseases. Shortly after their discovery, they were linked to asthma by Ernst V. von Leyden, and, ever since, controversies regarding the function and consequences of the eosinophil in asthma have existed. More recently, however, the utility of anti–IL-5 therapy in the management of a subset of patients with severe asthma have brought some of those issues to rest (2). The exact mechanisms by which eosinophils impact the airways in asthma were still unclear. Tissue damage induced by eosinophil degranulation products major basic protein-1 (MBP-1) and eosinophil peroxidase (EPX) has long been believed to be the culprit until now. In elegant work published in this issue of the Journal, Jacobsen and colleagues (pp. 1321–1332) revealed that IL-13–dependent Th2 immunoregulatory mechanisms, rather than the main degranulation products MBP-1 and EPX, contribute to inflammation, airway wall remodeling, and airway resistance (3). I5/hE2 double-transgenic mice overexpressing IL-5 in T cells and eotaxin-2 in airway epithelium develop severe asthma spontaneously with extensive eosinophil degranulation. The authors created a series of knockout models using this unique double-transgenic mouse to build proof-of-concept evidence that eosinophils are upstream initiator cells of Th2 asthma. Eosinophil-deficient I5/hE2/PHIL mice demonstrated that inflammatory cell infiltration; mucus cell metaplasia; airway fibrosis; elevated IL-4, IL-13, and T-cell chemoattractant TARC; and recruitment of T cells in the lungs were all dependent on eosinophils, as these responses were blocked in the double-transgenic mice after crossbreeding with PHIL mice. I5/hE2 mice did not show increase in Th1 or Th17 cytokines, clearly demonstrating that eosinophils set the stage specifically for a pulmonary Th2 microenvironment. Airway inflammation and remodeling (goblet cell metaplasia and collagen deposition) and IL-4 levels were blunted in I5/hE2/IL-13 mice, but only partially inhibited in I5/hE2/CD4 mice, demonstrating that the eosinophil-mediated effects were regulated by IL-13. Although flow cytometric analysis convincingly identified eosinophils in the bronchoalveolar lavage as a source of IL-13, their relative contribution to IL-13 produced by other (non-T) cells remains to be further investigated. Indeed, airway epithelial cell are also able to secrete IL-13, which may be regulated by eosinophils (4, 5). Compared with naive wild-type mice, airway resistance was increased in I5/hE2 mice, which was also dependent on IL-13, but not CD4. Interestingly, eosinophil degranulation appeared to be independent of IL-13 or CD4. Moreover, I5/hE2/EPX and I5/hE2/MBP mice had similar eosinophil infiltration and degranulation (pattern) and airway fibrosis compared with I5/hE2 mice, but mucus cell metaplasia was decreased in I5/hE2/EPX mice. Airway hyperreactivity was unaffected by EPX or MBP deficiency. Unfortunately, it was not possible to study potential interactions between EPX and MBP, because I5/hE2/EPX/MBPmice failed to produce mature peripheral eosinophils. The findings in this work by Jacobsen and colleagues reveals a previously unrecognized critically mechanistic role of eosinophils in Th2 airway inflammation independent of main eosinophil degranulation products EPX and MBP and shed light on the biological action mechanisms of anti-eosinophil therapies (3). The findings demonstrate that eosinophils belong to the group of upstream asthma-initiating hematopoietic cells, such as innate lymphoid cells (6) and proangiogenic hematopoietic progenitor cells (7). Most importantly, the data suggest that targeting of eosinophils in patients may suppress the pulmonary Th2 microenvironment and provide clinical benefit in asthma. Collectively, murine models of asthma are able to dissect mechanisms of inflammation that are as yet unattainable in human studies and help to provide us with a clearer understanding of our complex immune system. It was, in fact, the mouse model that was first to describe the Th1/Th2 paradigm, and throughout the years both human studies and murine models provided insight into this phenomenon. However, almost a decade after these initial observations by Mosmann and colleagues (8), investigators were discovering small cracks in the Th2 hypothesis regarding asthma pathogenesis with the observation of activated Th1 cells in humans and murine models of asthma. The variety of permutations used in this article by Jacobsen and colleagues was able to answer questions unattainable in human studies (3); despite this, one could argue about the artificial nature of such systems and whether it truly represents the human immune response in which inflammation and exposure to inciting stimuli is a continuously active and ongoing process. We now know that asthma is a complex disease with multiple pathways leading to common findings of airway inflammation and airway hyperresponsiveness. However, as a result of these early observations, it is not surprising that the first biologics available for asthma targeted the Th2-high phenotype. Omalizumab and the recently approved anti–IL-5 antibodies targeting Th2-high asthma have shown significant promise in the management of this asthmatic subgroup, yet even in appropriately selected patient populations up to one-third of patients do not respond to therapy. An interesting side note to this is that extended treatment with anti-IgE significantly reduced airway wall thickness and reticular basement membrane thickness, and this effect was independent of eosinophilic infiltration (9), which supports the work presented in this article. Thus, it will be interesting to see what information we can glean from the use of the anti–IL-5 antibodies, with the hope that they will provide us more insight into the role and function of this ancient cell. n